# Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.

> **NCT07429227** · NA · RECRUITING · sponsor: **Casa di Cura Dott. Pederzoli** · enrollment: 15 (estimated)

## Conditions studied

- Acute Coronary Syndromes (ACS)

## Interventions

- **DIETARY_SUPPLEMENT:** Tea tree (Melaleuca alternifolia), Cinnamon (Cynnamomum zeylanicum) bark, Clove carnation (Eugenia caryopyllus) flowers, Red thyme (Thymus vulgaris) plant

## Key facts

- **NCT ID:** NCT07429227
- **Lead sponsor:** Casa di Cura Dott. Pederzoli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429227, "Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07429227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*